Press Releases

NYSE: ACB | TSX: ACB  EDMONTON, Sept. 3, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (NYSE | TSX: ACB), today announced that it has scheduled its conference call to discuss the results for its fourth quarter and fiscal year ended June 30, 2019 on Thursday, September 12

Read more...

NEWARK, Calif., Sept. 3, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (NASDAQ:PTGX) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will provide a corporate overview at the H.C. Wainwright & Co. 2019 Annual Healthcare Conference in New York. Pres

Read more...

BOSTON, Sept. 3, 2019 /PRNewswire/ -- Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization o

Read more...

FRISCO, Texas, Sept. 3, 2019 /PRNewswire/ -- Addus HomeCare Corporation (Nasdaq: ADUS) ("Addus" or the "Company"), a provider of comprehensive home care services, today announced that it has commenced a proposed public offering of 2,000,000 shares of its common stock. In addition, funds affiliated with Eos Partners (the "Selling Stockholders") intend to

Read more...

MUNCIE, Ind., Sept. 3, 2019 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in Muncie on September 3rd and is located just west of KinderCare, across the street from McDonald's and nearby the Ball State University Campus. Athletico is

Read more...

SILVER SPRING, Md., Sept. 3, 2019 /PRNewswire/ -- A federal court has ordered two Tennessee-based companies and their owner to stop distributing drugs, dietary supplements and devices until the companies comply with the Federal Food, Drug, and Cosmetic (FD&C) Act and other requirements listed in a consent decree. According to the com

Read more...

CONCORD, Mass., Sept. 3, 2019 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and

Read more...

LA JOLLA, Calif., Sept. 3, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of in

Read more...

DES PLAINES, Ill., Sept. 3, 2019 /PRNewswire/ -- Illinois Bone & Joint Institute (IBJI), one of the largest independent, physician-owned orthopedic practices in the United States, is excited to welcome

Read more...